Theron Pharmaceuticals Secures $409,099 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dbe100ac-d691-41c3-98ad-7c775dd37d87
Date
8/6/2015
Company Name
Theron Pharmaceuticals
Mailing Address
365 San Aleso Avenue Sunnyvale, CA 94085 USA
Company Description
Founded in 2008, Theron Pharmaceuticals is a privately held biotechnology company developing a best-in-class, long acting M3 muscarinic antagonist (LAMA) for the improved treatment of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and severe asthma.
Website
http://www.theronpharma.com
Transaction Type
Venture Equity
Transaction Amount
$409,099
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor
Undisclosed